Dietary modulation of endothelial function: Implications for cardiovascular disease

American Journal of Clinical Nutrition

Volumn 73, Issue 4, 2001, Pages 673-686

  Brown, A A ^a   Hu, F B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antioxidants; Cardiovascular disease; Diabetes; Endothelial function; Folic acid; L arginine; n 3 fatty acids; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; FOLIC ACID; OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL FUNCTION; DIABETES MELLITUS; DIET; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; REVIEW; SMOKING; VASCULAR ENDOTHELIUM;

EID: 0035083871     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/73.4.673     Document Type: Review

References (141)

1. The endothelium: A new target for therapy
2. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multipstep paradigm
3. Atherosclerosis - An inflammatory disease
4. Coronary risk factors, endothelial function and atherosclerosis: A review
5. Primary endothelial dysfunction: Atherosclerosis
6. The L-arginine-nitric oxide pathway
7. Fluid flow inhibits endothelial adhesiveness: Nitric oxide and transcriptional regulation of VCAM-1
8. Omega-3 fatty acids alter soluble markers of endothelial function in coronary heart disease patients
9. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
10. Close relation of endothelial function in the human coronary and peripheral circulations
11. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions
12. The expression of adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
13. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions
14. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) Study
15. New indices of ischemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease
16. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin
17. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
18. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effects of intensive insulin treatment
19. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and NIDDM patients
20. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: The possible role of oxidative stress
21. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
22. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans
23. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis
24. Specific impairment of endothelium-dependent vasodilation in subjects with type II diabetes independent of obesity
25. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein
26. The influence of smoking on soluble adhesion molecules and endothelial cell markers
27. Even moderate cigarette smoking influences the pattern of circulating monocytes and concentration of sICAM-1
28. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
29. Highdensity lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
30. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity
31. Dyslipidemia in diabetes mellitus
32. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
33. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
34. Hormone replacement therapy and increased plasma concentrations of C-reactive protein
35. Effect of exercise on coronary endothelial function in patients with coronary artery disease
36. Chronic antioxidant use and changes in endothelial dysfunction: A review of clinical investigations
37. Atherosclerosis in Alaska natives and non-natives
38. Cardiovascular deaths among Alaskan natives, 1980-1986
39. Epidemiological studies in Upernavik District, Greenland
40. The composition of food consumed by Greenland Eskimos
41. Eicosapentaenoic acid and platelet function in Japanese
42. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular disease
43. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
44. Fish consumption and the 30-year risk of fatal myocardial infarction
45. Fish consumption and the risk of sudden cardiac death
46. Fish consumption and cardiovascular disease in the Physicians' Health Study: A prospective study
47. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary heart disease among men
48. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART)
49. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results from the GISSI-Prevenzione trial
50. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies
51. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review
52. n-3 fatty acids and the prevention of coronary atherosclerosis
53. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids
54. Fatty acid modulation of endothelial activation
55. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia
56. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells
57. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha
58. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyteendothelial adhesion
59. Structural requirements for inhibition of cytokine-induced endothelial activation by unstaturated fatty acids
60. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells
61. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients
62. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients
63. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion
64. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
65. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease
66. Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins
67. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease
68. Vitamin E consumption and the risk of coronary disease in women
69. Vitamin E consumption and the risk of coronary heart disease in men
70. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
71. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
72. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly
73. Vitamin C intake and mortality among a sample of the United States population
74. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
75. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease
76. Vitamin E supplementation and cardiovascular events in high-risk patients
77. Vitamin E and heart disease: Basic science to clinical intervention trials
78. Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation
79. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits
80. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes
81. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells
82. Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings
83. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1beta, and monocyte adhesion to endothelium
84. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers
85. Increased levels of soluble P-selectin in hypercholesterolemic patients
86. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
87. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
88. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
89. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease
90. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy
91. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults
92. Oral vitamin C and endothelial function in smokers: Short-term improvement, but no sustained beneficial effect
93. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers
94. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: A randomized, placebo-controlled study
95. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers
96. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia
97. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
98. Micronutrients in cardiovascular nutrition: Rationale and dosing considerations
99. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
100. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
101. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamin B6, B12, and folate
102. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women
103. Dietary folate and risk of cardiovascular mortality: Results from the Multiple Risk Factor Intervention Trial (MRFIT)
104. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
105. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomized, placebocontrolled trial
106. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study
107. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study
108. Vascular effects of homocysteine: Therapeutic implications
109. Influence of folic acid on postprandial endothelial dysfunction
110. Homocysteine and endothelial dysfunction: A link with cardiovascular disease
111. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo
112. Homocysteine provokes leukocyteendothelium interaction by downregulation of nitric oxide
113. Promotion of vascular smooth muscle growth by homocysteine: A link to atherosclerosis
114. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
115. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
116. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults
117. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects
118. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: Restoration by folic acid
119. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease
120. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia
121. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial
122. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
123. Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction
124. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
125. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia
126. Folic acid reverts dysfunction of endothelial nitric oxide synthase
127. Role of arginine, taurine and homocysteine in cardiovascular diseases
128. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease
129. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults
130. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine
131. Syndrome X and endothelial dysfunction
132. Long-term L-arginine supplementation improves small vessel coronary endothelial function in humans
133. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation
134. Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: A double-blind study
135. Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoffs
136. Oral L-arginine in patients with coronary artery disease on medical management
137. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women
138. Arginine intake and risk of coronary heart disease mortality in elderly men
139. Dietary protein and risk of ischemic heart disease in women
140. Nut consumption and risk of coronary heart disease: A review of epidemiologic evidence